BioMed Research International

BioMed Research International / 2016 / Article
Special Issue

Neurodegeneration: Etiologies and New Therapies 2016

View this Special Issue

Editorial | Open Access

Volume 2016 |Article ID 8363179 | 1 page | https://doi.org/10.1155/2016/8363179

Neurodegeneration: Etiologies and New Therapies 2016

Received03 Oct 2016
Accepted05 Oct 2016
Published03 Nov 2016

In this special issue, we have 9 articles that highlight diverse biochemical, immunological, molecular, and neuroimaging techniques used to decipher the pathophysiological mechanisms underpinning neurodegeneration in various cellular and animal models. The common diseases are covered, including a review on the therapeutic options in Alzheimer’s disease and a discussion on the factors influencing homocysteine levels in Parkinson’s disease. Of particular interest in this issue is an article on the entity of “chemo brain,” a condition that overlaps between oncology and neurology. “Chemo brain” is a common term used to describe thinking and memory problems that can occur after cancer treatment. Here the authors demonstrate PET evidence of the effect of donepezil on cognitive performance in an animal model. We hope this special issue will generate further interest and debate on the pathoetiology of neurodegenerative diseases and provide a platform to generate impetus to further identify and validate new therapeutic options.

Eng King Tan
Amit K. Srivastava
W. David Arnold
Mahendra P. Singh
Yiying Zhang

Copyright © 2016 Eng King Tan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

467 Views | 201 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.